Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up

NCT ID: NCT01255982

Last Updated: 2012-10-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

249 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-03-31

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to study prospectively for 8 months a sample of bipolar patients with acute depressive episode in order to identify that factors associated with functional impairment, with especial attention to the presence of subsyndromal symptoms beyond the acute phase.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder Bipolar Depression

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Bipolar depression subsyndromal symptoms functioning cognitive function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Diagnosed with bipolar I or II disorder, and with an acute episode of bipolar depression at inclusion

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Bipolar Disorder I or II (DSM-IV-TR)
* Acute depressive episode at inclusion

Exclusion Criteria

* Inability (in investigator´s opinion) to carry out the follow-up plan
* Patients participating or having participated within previous 6 months, in clinical trials
* Mental retardation or any other medical condition affecting cognitive performance
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Elche, Alicante, Spain

Site Status

Research Site

Villajoyosa, Alicante, Spain

Site Status

Research Site

Almería, Almería, Spain

Site Status

Research Site

Barcelona, Barcelona, Spain

Site Status

Research Site

Granollers, Barcelona, Spain

Site Status

Research Site

San Boit de LLobregat, Barcelona, Spain

Site Status

Research Site

Córdoba, Cordoba, Spain

Site Status

Research Site

Granada, Granada, Spain

Site Status

Research Site

Lleida, Lerida, Spain

Site Status

Research Site

Monforte de Lemos, Lugo, Spain

Site Status

Research Site

Madrid, Madrid, Spain

Site Status

Research Site

Málaga, Malaga, Spain

Site Status

Research Site

Tudela, Navarre, Spain

Site Status

Research Site

Ourense, Orense, Spain

Site Status

Research Site

Palencia, Palencia, Spain

Site Status

Research Site

Palma de Mallorca, Palma de Mallorca, Spain

Site Status

Research Site

Mos, Pontevedra, Spain

Site Status

Research Site

Langreo, Principality of Asturias, Spain

Site Status

Research Site

Seville, Sevilla, Spain

Site Status

Research Site

Tarragona, Tarragona, Spain

Site Status

Research Site

Catarroja, Valencia, Spain

Site Status

Research Site

Valencia, Valencia, Spain

Site Status

Research Site

Zamora, Zamora, Spain

Site Status

Research Site

Zaragoza, Zaragoza, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-NES-DUM-2010/1

Identifier Type: -

Identifier Source: org_study_id